Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Fig. 5

Changes in anti-dsDNA levels a in sera where data were obtained with conventional measurements and b in solubilized IC for the belimumab-treated SLE patients, in relation to therapy response. In each panel, data are shown for all 53 patients with full data to the left, for the 22 patients not attaining cSLEDAI-2K=0 in the middle, and for the 31 patients attaining cSLEDAI-2K=0 to the right. Horizontal bars represent median values, which are also presented below each measure

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us